NasoVAX (intranasal flu vaccine) / Altimmune  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
NasoVAX (intranasal flu vaccine) / Altimmune
NCT00755703: Safety and Immunogenicity Study of Adenovirus-vectored, Intranasal Pandemic Influenza Vaccine.

Completed
1
48
US
Pandemic Influenza Vaccine, Placebo
Altimmune, Inc.
Influenza A Subtype H5N1 Infection
09/09
12/11

Download Options